Sperl S, Bergner A, Stürzebecher J, Magdolen V, Bode W, Moroder L
Max-Planck-Institut für Biochemie, Martinsried, Germany.
Biol Chem. 2000 Apr;381(4):321-9. doi: 10.1515/BC.2000.042.
Hydrophobic urethanyl derivatives of 3-amidinophenylalanine methyl ester were found to be relatively potent and selective factor Xa inhibitors. These compounds consist of the arginine-mimetic 3-benzamidino group as P1 residue and of hydrophobic residues as potential interaction partners for the S3/S4 aryl binding site of the enzyme. Attempts to possibly identify their binding mode to factor Xa via the X-ray crystal structure of a trypsin/inhibitor complex and analogy modeling on the crystal structure of factor Xa failed. However, synthesis of enantiomerically pure (R)- and (S)-derivatives, combined with modeling experiments, led to an hypothetical non-substrate like binding mode, which was fully confirmed by the remarkably enhanced inhibitory potency of derivatives in which the methyl ester was replaced by arylamides for interactions with the S3/S4 enzyme binding subsites. With adamantyloxycarbonyl-(R)-3-amidinophenylalanine-phenethylamide+ ++ a nanomolar inhibiton was obtained, thus indicating this new class of factor Xa inhibitors as a highly promising lead structure.
3-脒基苯丙氨酸甲酯的疏水脲基衍生物被发现是相对强效且具有选择性的凝血因子Xa抑制剂。这些化合物由作为P1残基的精氨酸模拟物3-苯甲脒基和作为该酶S3/S4芳基结合位点潜在相互作用伙伴的疏水残基组成。试图通过胰蛋白酶/抑制剂复合物的X射线晶体结构以及基于凝血因子Xa晶体结构的类比建模来确定它们与凝血因子Xa的结合模式,但均未成功。然而,对映体纯的(R)-和(S)-衍生物的合成,结合建模实验,得出了一种假设的非底物样结合模式,这一模式通过将甲酯替换为芳基酰胺以与S3/S4酶结合亚位点相互作用的衍生物显著增强的抑制效力得到了充分证实。对于金刚烷氧基羰基-(R)-3-脒基苯丙氨酸-苯乙酰胺,获得了纳摩尔级的抑制效果,从而表明这类新型凝血因子Xa抑制剂是一种极具前景的先导结构。